Your browser doesn't support javascript.
loading
Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial.
Rosenzwajg, Michelle; Lorenzon, Roberta; Cacoub, Patrice; Pham, Hang Phuong; Pitoiset, Fabien; El Soufi, Karim; RIbet, Claire; Bernard, Claude; Aractingi, Selim; Banneville, Beatrice; Beaugerie, Laurent; Berenbaum, Francis; Champey, Julien; Chazouilleres, Olivier; Corpechot, Christophe; Fautrel, Bruno; Mekinian, Arsène; Regnier, Elodie; Saadoun, David; Salem, Joe-Elie; Sellam, Jérémie; Seksik, Philippe; Daguenel-Nguyen, Anne; Doppler, Valérie; Mariau, Jéremie; Vicaut, Eric; Klatzmann, David.
Afiliación
  • Rosenzwajg M; Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • Lorenzon R; Immunology-Immunopathology- Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
  • Cacoub P; Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • Pham HP; Immunology-Immunopathology- Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
  • Pitoiset F; Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • El Soufi K; Immunology-Immunopathology- Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
  • RIbet C; Department of Internal Medicine and Clinical Immunology, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • Bernard C; ILTOO Pharma, Paris, France.
  • Aractingi S; Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • Banneville B; Immunology-Immunopathology- Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
  • Beaugerie L; Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • Berenbaum F; Immunology-Immunopathology- Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
  • Champey J; Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • Chazouilleres O; Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • Corpechot C; Immunology-Immunopathology- Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
  • Fautrel B; Department of Dermatology, AP-HP Cochin Hospital, Paris, France.
  • Mekinian A; Department of Rheumatology, AP-HP Pitié-Salpêtrière Hospital, Paris, France.
  • Regnier E; Department of Gastroenterology, AP-HP Saint Antoine Hospital, Paris, France.
  • Saadoun D; Department of Rheumatology, AP-HP Saint-Antoine Hospital, Paris, France.
  • Salem JE; Department of Rheumatology, AP-HP Saint-Antoine Hospital, Paris, France.
  • Sellam J; Department of Hepatology, AP-HP Saint-Antoine Hospital, Paris, France.
  • Seksik P; Department of Hepatology, AP-HP Saint-Antoine Hospital, Paris, France.
  • Daguenel-Nguyen A; Department of Rheumatology, AP-HP Pitié-Salpêtrière Hospital, Paris, France.
  • Doppler V; Department of Internal Medicine, AP-HP, Saint-Antoine Hospital, Paris, France.
  • Mariau J; Department of Dermatology, AP-HP Cochin Hospital, Paris, France.
  • Vicaut E; Inflammation-Immunopathology-Biotherapy Department (i2B), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • Klatzmann D; Immunology-Immunopathology- Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
Ann Rheum Dis ; 78(2): 209-217, 2019 02.
Article en En | MEDLINE | ID: mdl-30472651
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Interleucina-2 / Linfocitos T Reguladores / Factores Inmunológicos Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Año: 2019 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Interleucina-2 / Linfocitos T Reguladores / Factores Inmunológicos Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Año: 2019 Tipo del documento: Article País de afiliación: Francia